Loading chart…
PRE-MARKET
Haleos Labs Limited engages in the manufacturing of active pharmaceutical ingredients (API) and intermediates in India. The company offers API and intermediates in areas, such as anti-ulcer, anti-migraine, anti-hypertensive, erectile dysfunction, anti-cancer, antifungal, anti-obesity, anti-emetic, anti-depressant, anti-worm, anti-infective, anti-gout, anti-convulsant, antiviral, and anesthesia, as well as antihistamine, diuretics, hair loss, and ophthalmic API products. It also export its products.
Haleos Labs Limited (HALEOSLABS) is listed on the NSE in the Healthcare sector, Biotechnology industry. The HALEOSLABS share price is ₹1,400.40 (-0.67% today), with a market capitalisation of ₹4B and a price-to-earnings (P/E) ratio of 26.8. MarketRipple tracks the HALEOSLABS investment thesis, the ripple-chain impact of market events on Haleos Labs Limited, and the Healthcare sector outlook.
Open
₹1,405.70
High
₹1,405.70
Low
₹1,398.80
Prev. Close
₹1,409.80
52W High
₹1,774.00
52W Low
₹1,091.10
Day range
₹1,398.80–₹1,405.70
52-week range
₹1,091.10–₹1,774.00
Volume
445
P/E
26.8
ROE
8.1%
D/E
0.52
Margin
4.9%
Haleos Labs Limited (NSE: HALEOSLABS) is currently trading at ₹1,400.40 (-0.67%).
Haleos Labs Limited's market capitalization is ₹4B.
Haleos Labs Limited's price-to-earnings (P/E) ratio is 26.8.
Haleos Labs Limited operates in the Healthcare sector (Biotechnology).